Today's drug development landscape demands the latest technologies, advanced capabilities, and above all flexibility. From overcoming development and manufacturing complexities to working faster and smarter, CDMOs provide the flexibility needed to meet ever-changing drug development needs providing therapeutic expertise and sophisticated capabilities to help advance drugs to market.
This CDMO Showcase highlights companies that excel in supporting pharma innovators, helping them meet aggressive timelines and achieve stronger financial outcomes.
Abzena is the leading end-to-end CDMO + CRO for bioconjugates & complex biologics (ADCs, AOCs, RDCs, Bi/Multi-specifics). From discovery through commercial, we support customers with fully integrated programs or individual services that reduce risk and streamline programs to IND and beyond. With over 25 years of experience, 2,000+ conjugates developed, and footholds in the US and UK, we provide a simplified & secure supply chain.
At Altasciences, we’re redefining what a CDMO can be. Instead of juggling multiple vendors, you get a fully integrated development and manufacturing model—formulation, analytical testing, preclinical, and clinical studies all under one roof. Fewer handoffs. Faster answers. Smarter decisions. Our teams streamline your path from concept to clinic to commercial scale with seamless formulation development, Phase I through commercial manufacturing, and ICH stability services. With 30+ years of hands-on expertise in small molecules and advanced processes, we’ve worked across nearly every dosage form imaginable—tablets, liquid- and powder-filled capsules, over-encapsulation, nanomilled suspensions, spray-dried dispersions, creams, gels, and terminally sterilized injectables. One partner. One continuous workflow. Accelerated progress.
Bora Biologics is a U.S.-based CDMO specializing in late-stage and commercial biologics manufacturing. With FDA-approved infrastructure in San Diego and integrated development capabilities in Taiwan, Bora Biologics supports programs from early development through commercial supply. Our recent 2,000L expansion in San Diego strengthens mammalian capacity, enabling sponsors to scale with regulatory confidence, operational resilience, and the infrastructure required for pivotal trials, licensure, and global commercialization.
Flamma is an award-winning CDMO delivering Chemistry with a Human Touch. Since 1950, we have combined deep scientific expertise with global operational strength. Our FDA-inspected U.S. site in Malvern, PA specializes in early-stage cGMP manufacturing of small molecule APIs, NCEs, RSMs & intermediates.
Supported by five cGMP facilities worldwide, Flamma provides seamless scale-up from grams to kilos to MTs through a secure, reliable, and fully integrated supply chain designed to reduce risk and accelerate timelines.
Flamma delivers more than small molecule drug development & manufacturing. We bring the Chemistry of Values: transparency, responsiveness & technical rigor while striving for long-term partnerships to confidently advance your molecule from development to commercialization.
As a global CDMO, we develop and manufacture complex parenteral products requiring close coordination across development, tech transfer, and commercial manufacturing. We also support both large and small projects, managing small volume parenterals and small molecule projects from formulation to commercial scale. Our expertise includes flexible bags, glass vials, high quality diluents and intravenous specialties. Our FDA approved facilities in Spain ensure the highest standards of quality and safety. Grifols, your CDMO for complex parenterals.
Grifols International, S. A. Av. de la Generalitat, 152 08174 Sant Cugat del Valles Barcelona Spain 34-670-923-382 34-93-571-21-99 [email protected] www.partnership.grifols.com
Hubot, Inc. is a turn-key Contract Development and Manufacturing (CDMO) partner for aerosols, liquids, tubes, foams, creams, suppositories and gels specializing in Medical Devices, Consumer Healthcare (OTC - Topical, Oral), Health & Wellness and Personal Care. Headquartered in South Bend, IN, Hubot CDMO is located in two (2) facilities totalling 130,000 sq. ft. GMP manufacturing is located within a 65,000 sq. ft. FDA Registered facility and houses intrinsically safe ISO 8 Cleanroom suites for aerosol, foam, liquid tube filling and bulk blending.
PCI is a global CDMO, providing integrated end-to-end drug development, manufacturing, and packaging solutions across the product lifecycle, ultimately increasing speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades delivering CDMO services. With 38 sites across Australia, Canada, North America, the UK and Europe and over 7,500 dedicated employees, together, we deliver life-changing therapies to patients.
Quotient Sciences brings 35+ years of trusted scientific insight, quality, and control to drug development with a mission to help our customers bring new molecules to patients faster. We provide a full range of drug product (CDMO) and clinical (CRO) services, which can be tightly integrated with Translational Pharmaceutics®—a disruptive platform to enable greater efficiency, better outcomes, and reduced timelines in development.
Upperton is a UK-based CDMO with proven expertise in the development, scale-up, manufacture and testing of oral, nasal, pulmonary and sterile drug products. With 25 years’ experience and state-of-the-art facilities featuring R&D, QC and GMP on one site, Upperton offers a science-led approach to accelerate drug development from pre-clinical to market. With regulatory confidence and experience, Upperton excels at providing flexibility, expertise, rapid project initiation and unparalleled project delivery.
